UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000029529
Receipt No. R000033742
Scientific Title Establishment of effective muscular strength training method for Arthrogenic muscle inhibition
Date of disclosure of the study information 2017/10/12
Last modified on 2017/10/12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Establishment of effective muscular strength training method for Arthrogenic muscle inhibition
Acronym Establishment of effective muscular strength training method for Arthrogenic muscle inhibition
Scientific Title Establishment of effective muscular strength training method for Arthrogenic muscle inhibition
Scientific Title:Acronym Establishment of effective muscular strength training method for Arthrogenic muscle inhibition
Region
Japan

Condition
Condition Healthy adults
Classification by specialty
Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To Establish effective muscle strength training for Arthrogenic muscle inhibition.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes pre- and post-treatment assessment by H/M ratio under the pain condition.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine Other
Interventions/Control_1 Hypertonic saline injection
Continue administration at 0.15ml/min for 20 minutes
Interventions/Control_2 Isotoni saline injection for control
Continue administration at 0.15ml/min for 20 minutes
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
50 years-old >
Gender Male and Female
Key inclusion criteria A volunteer aged between 20 and 50 without muskloskeletal pain.
Key exclusion criteria 1) chronic muskloskeletal pain
2) Oral administration of anti-inflammatory analgesic
3) mental illness
4) abnormality blood pressure
Target sample size 15

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Oda Shota
Organization Kochi Medical School Hospital
Division name Department of Rehabilitation Center
Zip code
Address Oko-cho Kohasu, Nankoku, Kochi, Japan 783-8505
TEL 088-880-2490
Email jm-s.oda@kochi-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Oda Shota
Organization Kochi Medical School Hospital
Division name Department of Rehabilitation Center
Zip code
Address Oko-cho Kohasu, Nankoku, Kochi, Japan 783-8505
TEL 088-880-2490
Homepage URL
Email jm-s.oda@kochi-u.ac.jp

Sponsor
Institute Kochi Medical School Hospital
Institute
Department

Funding Source
Organization Kochi Medical School Hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 10 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 10 Month 01 Day
Date of IRB
Anticipated trial start date
2017 Year 10 Month 13 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2017 Year 10 Month 12 Day
Last modified on
2017 Year 10 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033742

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.